Loading...

Advicenne S.A.

ADVIC.PAEURONEXT
Healthcare
Biotechnology
6.50
0.00(0.00%)

Advicenne S.A. (ADVIC.PA) Stock Overview

Explore Advicenne S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.9/100

Key Financials

Market Cap0
P/E Ratio-2.26
EPS (TTM)$-1.77
ROE0.44%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ADVIC.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Advicenne S.A. (ADVIC.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.26 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;